AIDA OTC
Aida Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +50.0%
3Y: -97.0%
5Y: -97.1%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$29M
-1.5% ▼
3Y CAGR: +23.1%
Gross Profit
$15M
-5.6% ▼
3Y CAGR: +10.1%
Operating Income
$5M
+38.3% ▲
3Y CAGR: +24.0%
Net Income
$3M
+88.4% ▲
3Y CAGR: +18.8%
EPS (Diluted)
$0.10
+66.7% ▲
3Y CAGR: +12.7%
EBITDA
$7M
+21.7% ▲
3Y CAGR: +26.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2004 | FY2005 | FY2006 | FY2007 |
|---|---|---|---|---|
| Revenue | $16M | $25M | $30M | $29M |
| YoY Growth | +0.0% | +56.8% | +20.9% | -1.5% |
| Cost of Revenue | $5M | $8M | $14M | $15M |
| Gross Profit | $11M | $16M | $16M | $15M |
| Gross Margin | 70.5% | 66.0% | 52.5% | 50.3% |
| R&D Expenses | $263K | $39K | $325K | $284K |
| SG&A Expenses | $8M | $14M | $11M | $9M |
| Operating Expenses | $8M | $14M | $12M | $9M |
| Operating Income | $3M | $2M | $4M | $5M |
| Operating Margin | 18.3% | 8.6% | 13.3% | 18.6% |
| Interest Expense | $481K | $1M | $2M | $2M |
| Income Before Tax | $3M | $2M | $2M | $2M |
| Tax Expense | $151K | $145K | $173K | $360K |
| Net Income | $2M | $1M | $1M | $3M |
| Net Margin | 10.5% | 6.0% | 4.9% | 9.4% |
| EPS (Diluted) | $0.07 | $0.06 | $0.06 | $0.10 |
| EBITDA | $4M | $4M | $6M | $7M |
| Shares Outstanding | 23M | 23M | 26M | 27M |